NCT01463410
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler No drug interventions Not Available Not Available terminated NCT02086773
Red Cell Transfusion Goals in Patients With Acute Leukemias No drug interventions supportive_care 1 completed NCT00185523
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) No drug interventions Not Available Not Available terminated NCT02390752
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... treatment 1 recruiting NCT00504764
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) treatment 4 completed NCT04175587
Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL treatment 3 unknown_status NCT00465933
Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) No drug interventions treatment 4 completed NCT02309333
Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database No drug interventions Not Available Not Available terminated NCT00875745
Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) treatment 1 completed NCT01987297
Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL treatment 4 unknown_status NCT00003861
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia No drug interventions Not Available Not Available active_not_recruiting NCT00180128
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia prevention 4 unknown_status NCT01472107
Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy No drug interventions Not Available Not Available completed NCT00852709
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias treatment 1 terminated NCT00599937
APL93: Timing of CxT and Role of Maintenance No drug interventions treatment 3 completed NCT00675870
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia treatment 2 unknown_status NCT01404949
Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy treatment 2 completed NCT03096496
Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy No drug interventions Not Available Not Available unknown_status NCT02938858
French Registry of First-line Treatment of Acute Promyelocytic Leukemia No drug interventions Not Available Not Available unknown_status NCT02991066
Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia No drug interventions Not Available Not Available unknown_status NCT00413166
All-trans Retinoic Acid, and Arsenic +/- Idarubicin treatment 2 completed NCT05832320
Optimum Induction Therapy of Low-risk APL treatment Not Available recruiting NCT00907582
ASCT for Relapsed APL After Molecular Remission No drug interventions treatment 2 terminated NCT01334060
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation No drug interventions treatment 2 completed NCT02899169
Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) treatment 3 unknown_status NCT00520208
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL treatment 2 completed NCT01226303
Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia No drug interventions treatment 3 unknown_status NCT04251754
The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project No drug interventions Not Available Not Available recruiting NCT00408278
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) treatment 4 completed NCT06544109
Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients prevention 2 / 3 enrolling_by_invitation NCT03624270
Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia treatment 2 recruiting NCT01064570
AIDA 2000 Guidelines treatment 2 unknown_status NCT04562818
Results From a Mexican Acute Promyelocytic Leukemia. No drug interventions Not Available Not Available completed NCT04793919
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia treatment 2 recruiting NCT03751917
Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia Not Available Not Available recruiting NCT00985530
Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia treatment 1 terminated NCT04996030
A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia treatment 1 suspended NCT00591526
A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL) treatment 3 completed NCT00378365
Acute Promyelocytic Leukemia 2006 (APL) No drug interventions treatment 3 unknown_status NCT04687176
Frontline Oral Arsenic Trioxide for APL treatment 2 recruiting NCT01902329
A Safety Study of SGN-CD33A in AML Patients treatment 1 completed NCT02688140
Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia treatment 3 active_not_recruiting NCT00517712
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia treatment 2 / 3 unknown_status NCT00670150
New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia treatment 2 withdrawn NCT01910623
Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia No drug interventions Not Available Not Available completed